Product Information
CEFPROZIL 250 MG/5 ML SUSP is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.2015 per ML under NDC 57237003575. Its NADAC has been published 638 times since Apr 9, 2014.
Strength
250 mg/5mL
Manufacturer
Rising Pharma Holdings Inc.NDC
57237003575
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CEFPROZILApproval Type
Generic (ANDA)
FDA Application
ANDA065381On Market Since
1/30/2007
Price Statistics
The NADAC for CEFPROZIL 250 MG/5 ML SUSP has been published 638 times since Apr 9, 2014, and over the history we have for it it has declined 62.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2015 per ML |
|---|---|
| All-time high | $0.5641 (Jun 11, 2014) |
| All-time low | $0.1433 (Aug 21, 2024) |
| 52-week high | $0.2117 |
| 52-week low | $0.1655 |
| Median price | $0.2671 |
| Average price | $0.3231 |
| Largest weekly change | +58.3% (Feb 23, 2022) |
| Weeks tracked | 638 |
| Tracking since | Apr 9, 2014 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 18% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CEFPROZIL 250 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for CEFPROZIL 250 MG/5 ML SUSP, manufactured by Rising Pharma Holdings Inc., is $0.2015 per ML (NDC 57237003575), effective Jun 24, 2026.
How has the price of CEFPROZIL 250 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for CEFPROZIL 250 MG/5 ML SUSP has declined 62.0%. It has been tracked across 638 weekly CMS publications since Apr 9, 2014.
What are the highest and lowest recorded NADAC prices for CEFPROZIL 250 MG/5 ML SUSP?
Since Apr 9, 2014, the NADAC for CEFPROZIL 250 MG/5 ML SUSP has ranged from a low of $0.1433 (Aug 21, 2024) to a high of $0.5641 (Jun 11, 2014), with a median of $0.2671 per ML.
Are there cheaper alternatives to CEFPROZIL 250 MG/5 ML SUSP?
Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, CEFPROZIL 250 MG/5 ML SUSP, is $0.1655 per ML — about 18% below CEFPROZIL 250 MG/5 ML SUSP.
Who manufactures CEFPROZIL 250 MG/5 ML SUSP?
CEFPROZIL 250 MG/5 ML SUSP (NDC 57237003575) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification